Sweet REsponse!!! Bullseye! And again pretending to "be in the know" on exactly what the SEC is "up to." Presumptuous!
Meanwhile in Brazil, the Philippines, and now Canada >>>> CytoDyn's marvelous remedy LERONLIMAB is on the move!
Glad to see we are focusing more attention on indications beyond Covid-19. I'm very excited about Leronlimab's possibilities with PASC (Long Haulers'). Let's get those 200,000,000 shares to back us up and get the next trial underway!
Also, it doesn't hurt that while we're starting to accelerate our progress (including the first three main sections of the BLA submitted - and not by the 'typewriter monkeys' at Amarex, LOL), Merck is looking around for a partner to bolster its flagging position. Sounds like we and Todos are short listed. Wow!
IMO
Market Data 
Markets 
AI
